SynthesisKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2013
A meta-analysis of the sub-vastus approach and medial parapatellar approach in total knee arthroplasty.
Synthesis in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparison of the quadriceps-sparing and subvastus approaches versus the standard parapatellar approach in total knee arthroplasty: a meta-analysis of randomized controlled trials.BMC musculoskeletal disorders · 2015Pooled it
- Greater medial arterial supply revealed by 7-Tesla quantitative magnetic resonance imaging, histology and high-resolution computed tomography of the patellar tendon.Journal of experimental orthopaedics · 2026Article
- Robot-assisted total knee arthroplasty using modified sub-vastus approach: A series of 120 knees.Journal of clinical orthopaedics and trauma · 2025Article
- Comparable long-term functional outcomes of subvastus and medial parapatellar approach in total knee arthroplasty: A 10-year follow-up study.Journal of experimental orthopaedics · 2024Article
- Author's reply.Indian journal of orthopaedics · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBoth sub-vastus (SV) approach and standard medial parapatellar (MP) approach are performed in primary total knee arthroplasty (TKA). Proponents of SV approach stress its importance in decreasing lateral release and preserving function of the extensor mechanism with earlier rehabilitation. The purpose of this study was to summarize the best evidence to compare functional outcomes between SV approach and MP approach in TKA.
methodsAll relevant randomized controlled trials and quasi-randomized controlled trails comparing SV approach and MP approach in primary TKA were included, and the search strategy followed the requirements of the Cochrane Library Handbook. Methodological quality was assessed, and data were extracted independently by two authors.
resultsTen studies involving 976 knees, which compared the clinical outcomes after TKA by SV approach and MP approach, were included. The results showed that the SV approach needed less lateral release (RR, 0.37; 95 % CI, 0.17-0.81; P = 0.01) and offered earlier straight leg raise (95 % CI, -3.11 to -0.69; P < 0.01) and superior knee flexion within 1 week postoperation (95 % CI, 1.96-8.20; P < 0.01) with no increase in the duration of surgery.
conclusionsThe preliminary results can be concluded that SV approach may provide an alternative to the MP approach with earlier rehabilitation and decreased lateral release rates in primary TKA; however, more high-quality randomized controlled trials should be designed to assess the medium and long-term outcomes between these two approaches. LEVEL OF EVIDENCE: II.
Indexed as
Identifiers
22684429What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.